A Phase 2a, Randomised, Double-blind, Parallel Study to Assess the Efficacy, Safety and Tolerability of AZD9567 compared to Prednisolone 20 mg in patients with active Rheumatoid Arthritis (RA)
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2019
Price : $35 *
At a glance
- Drugs AZD 9567 (Primary) ; Prednisolone
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors AstraZeneca; AstraZeneca AB
- 05 Dec 2019 According to EudraCt record this trial has been Discontinued in Sweden.
- 26 Sep 2019 Planned End Date changed from 17 Sep 2020 to 28 Jan 2020.
- 26 Sep 2019 Planned primary completion date changed from 17 Sep 2020 to 28 Jan 2020.